"Clearly Novartis is willing to pay up for this and will most likely rely on its ability to expand the top-line primarily outside the U.S.," Leuchten said. Note to investorsNovartis has scheduled a conference call for members of the financial community to discuss this announcement on August 26, 2010, at 14:00 Central European Time. 'is_sponsored' : '0' , Neither can there be any guarantee that the proposed merger with Alcon will be completed in the expected form or within the expected time frame or at all. For related news and company statements click on NOVN.VX-LEN and NESN.VX-LEN, Editing by Paul Bolding, Elizabeth Fullerton. In April 7, 2008 press releases from Novartis AG and Alcon Inc., the companies announced that Novartis has reached an agreement with Nestlé S.A. which provides Novartis with the right to acquire majority ownership of Alcon Inc.  Nestlé currently owns 77% of the outstanding shares of Alcon. ZURICH (Reuters) - Novartis AG NOVN.VX has agreed to buy Nestle AG's NESN.VX 77 percent stake in U.S. company Alcon ACL.N in a deal worth up to $39 billion to boost its eye care business, the Swiss drugmaker said on Monday. "),a=0;a()[].,;:s@"]+(.[^=&/<>()[].,;:s@"]+)*)@(([[0-9]{1,3}.[0-9]{1,3}.[0-9]{1,3}.[0-9]{1,3}])|(([a-zA-Z-0-9]+. “The best way we believe to look at the transaction is further diversification of growth through a bolt-on acquisition ahead of the U.S. patent expiry of (top-seller) Diovan in 2012,” said Deutsche Bank analyst Michael Leuchten. A question about Nestlé’s brands, policies, or products? With the achievement of the 77% majority ownership, Novartis and Alcon will be able to create greater value together for all stakeholders through collaborations that would benefit both companies. All quotes delayed a minimum of 15 minutes. All Rights Reserved. }; } 'cag[device]' : 'web' , Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. Novartis has agreed to buy Nestle's percent stake in U.S. company Alcon in a deal worth up to $39 billion to boost its eye care business, the Swiss drugmaker said on Monday. Shares in Nestle closed 1 percent higher at 516.50 Swiss francs. if(typeof window.MediaSource !== 'function') { Additionally, Novartis submitted a proposal to Alcon’s board of directors to acquire the remaining 23% of its publicly-traded shares. mps._queue.mpsloaded.push(function(){ 2008) | {key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t("ee").get("jsonp"),f=t(24)(c);if(e.exports=c,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(. Enclose phrases in quotes. if (!mps._ext || !mps._ext.loaded) {

Bournemouth Logo Meaning, Petite Sundresses, Motorcity Episode 2, Bts V Girlfriend, Mixology Drinks, Frederick Douglass Quotes On Lincoln, Womens Cotton Shorts, Augustus Goggins, Jordan 6, Rounding Off Decimals Rules, Banana Republic, Primark Design, Global Partners News, Rental Property Value Calculator, Private Meaning In Tamil, How To Pronounce Pesach Sameach, Free Casey's Pizza, This Is The Way Meme, Brighton V Everton, Torino Vs Hellas Verona Prediction, Eurojackpot Uk, Fortitude Season 4, Call Monitoring, Truth Or Consequences Game Show Questions, Monsoon Slouch Boots, Post Office Manage My Account, Man With A Plan Online,